Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CardioComm Solutions Inc V.EKG

Alternate Symbol(s):  EKGGF

CardioComm Solutions, Inc. is a global medical provider of consumer heart monitoring and medical electrocardiogram (ECG) software solutions. The Company’s technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. It develops advanced software, hardware and core laboratory reading services related to ECG and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians. The Company is also engaged in manufacturing, marketing, and sales of personal ECG monitors direct to consumers. The products are marketed under the HeartCheck brand. It has developed compatibility of the HeartCheck device to its GEMS and GlobalCardio based software to enable use of the device for remote ECG/arrhythmia monitoring services.


TSXV:EKG - Post by User

Bullboard Posts
Post by penny001on Mar 04, 2013 3:57pm
288 Views
Post# 21075823

Prof. Langer holds 41 million shares of EKG.V

Prof. Langer holds 41 million shares of EKG.V


Anatoly Langer
MD, MSc, FRCPC, FACC
Chair, Canadian Heart Research Centre

Dr. Anatoly Langer graduated from the University of Manitoba in 1982 and completed his Internal Medicine and Cardiology training at the University of Toronto in 1987. He is a fellow of the American College of Cardiology and Canadian Royal College of Physicians and Surgeons.

After two years as a Heart and Stroke Foundation Research Fellow he became a director of the Coronary Care Unit at St. Michael’s Hospital in Toronto, Canada.

In 1996 Dr. Langer founded the Canadian Heart Research Centre with the goal of improving the care of cardiovascular patients through clinical trials research and education.

Dr. Langer has over 200 peer reviewed publications, abstracts and book chapters. His areas of interest and research include pathophysiology and the management of acute and stable coronary syndromes as well as the treatment and prevention of cardiovascular disease.

Currently Dr. Langer is a Professor of Medicine at the University of Toronto and a staff cardiologist at St Michael’s Hospital. He is Chair of the Canadian Heart Research Centre in Toronto.
Dr. Langer has extensive research experience in the conduct of clinical trials with over 15 years of experience in protocol design, study coordination and data management.

 

Bullboard Posts